Regulatory & Compliance
Supporting product development, market access and ongoing compliance.
Overview
Life Sciences organisations operate within one of Australia's most heavily regulated industries. From product development and market entry through to commercialisation and post-market compliance, regulatory obligations play a critical role throughout the product lifecycle.
We advise pharmaceutical, biotechnology businesses, medical device manufacturers and healthcare organisations on the legal and regulatory issues that arise when bringing products to market and maintaining compliance in an evolving regulatory environment.
Clients we've supported
- Bayer
- AstraZeneca
- Philips
- Amgen
- Edwards Lifesciences
- Eli Lilly
- Novartis
- Eisai
- Novo Nordisk
Get in touch